Is Ketamine Treatment Right for You? Questions for a Clinical Evaluation

Important: Compounded ketamine is not FDA-approved. FDA has not evaluated its safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric conditions. Compounded ketamine nasal spray is different from FDA-approved Spravato (esketamine), and research on other formulations or treatment settings does not establish its benefits.

An online checklist cannot determine whether ketamine is appropriate for you. A clinical evaluation should consider why you are seeking help, what you have tried, and whether the proposed care can meet your needs.

Bring a complete picture of your health

Prepare a list of prescription medicines, over-the-counter products, and supplements. Tell the clinician about alcohol and other substance use, prior medication reactions, and any history of difficulty controlling use of a substance. Accurate information helps the clinician assess risks without relying on assumptions.

Also discuss cardiovascular conditions, blood pressure, breathing problems, urinary symptoms, pregnancy or breastfeeding, and previous episodes of mania or psychosis. These are topics for individual assessment, not a self-screening tool or a complete eligibility list.

Discuss the reason for considering it

Explain the symptoms that interfere most with your life and describe earlier treatment attempts. Ask whether another assessment is needed and what approved treatments or nonmedication approaches are available. The NIMH depression overview can help you prepare for that broader conversation.

Evaluate the care plan as carefully as the medication

• Who will review progress and respond to concerns?
• What monitoring is needed during and after treatment?
• How will medication interactions and unwanted effects be addressed?
• What would lead to stopping, changing, or escalating care?
• Is an onsite setting or a higher level of care more appropriate?

If home treatment is discussed, be clear about the limits of remote support. A plan should explain what to do if you become too impaired to seek help or develop concerning symptoms. Having a virtual appointment does not create an onsite emergency response. For more questions to bring to that discussion, see our guide to ketamine risks and monitoring.

Keep the decision open

A reasonable outcome of a consultation may be further evaluation, another treatment, or no prescription. Ask for time to understand uncertainties and alternatives. Do not interpret access to an appointment or ability to pay as evidence that a medication is medically appropriate.

If you are experiencing a medical emergency or are in immediate danger, call 911 rather than waiting for routine scheduling.

Safety and the treatment setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, nausea, increased blood pressure or heart rate, and slowed breathing. Abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems are also concerns. This is not a complete list of risks.

At home, a healthcare professional is not onsite to monitor you or respond immediately to an adverse reaction. Telehealth support does not provide the same monitoring as an onsite care team. Review these FDA ketamine risk alerts and discuss your health history, other medications, monitoring needs, and emergency plan with your clinician.

Discuss your options

Bliss Mist Rx LLC provides telehealth services; we do not manufacture or compound medication. If a clinician prescribes treatment, an independent, appropriately licensed compounding pharmacy dispenses it. A consultation does not guarantee a prescription or a particular outcome. Book a Free Virtual Appointment or Follow-Up to discuss questions about your care.

This article is general education and does not replace individualized medical advice.